PharmaShots | Incisive News in 3 Shots

Subscribe Now

aTTP

Chugai's Rozlytrek Receives MHLW's Approval for ROS1 Fusion-Positive Non-Small Cell Lung Cancer

Chugai's Rozlytrek Receives MHLW's Approval for ROS1 Fusion-Positive Non-Small Cell Lung Cancer

February 21, 2020

Sanofi's Cablivi (caplacizumab-yhdp) Receives FDA's Approval for Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Adults

Sanofi's Cablivi (caplacizumab-yhdp) Receives FDA's Approval for Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Adults

February 7, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us